Secondary |
Prophylaxis |
11.3% |
Hypersensitivity |
9.7% |
Ill-defined Disorder |
7.3% |
Neuroendocrine Carcinoma |
6.5% |
Asthma |
5.6% |
Hiv Infection |
5.6% |
Bacterial Infection |
4.8% |
Infection |
4.8% |
Product Used For Unknown Indication |
4.8% |
Urinary Tract Infection |
4.8% |
Atrial Fibrillation |
4.0% |
Prophylaxis Of Nausea And Vomiting |
4.0% |
Status Epilepticus |
4.0% |
Disseminated Intravascular Coagulation |
3.2% |
Drug Use For Unknown Indication |
3.2% |
Ear Infection |
3.2% |
Inflammation |
3.2% |
Multiple Myeloma |
3.2% |
Pneumocystis Jiroveci Pneumonia |
3.2% |
Pneumonia Mycoplasmal |
3.2% |
|
Urinary Tract Infection |
14.7% |
Premature Rupture Of Membranes |
8.8% |
Weight Decreased |
8.8% |
Clostridial Infection |
5.9% |
Leukocytoclastic Vasculitis |
5.9% |
Renal Infarct |
5.9% |
Thrombocytopenia |
5.9% |
Tinea Infection |
5.9% |
Weight Increased |
5.9% |
Abdominal Discomfort |
2.9% |
Anaemia |
2.9% |
Asthma |
2.9% |
Blood Creatinine Increased |
2.9% |
Creatinine Renal Clearance Increased |
2.9% |
Developmental Delay |
2.9% |
Diarrhoea |
2.9% |
Ear Infection |
2.9% |
Epilepsy |
2.9% |
Hallucination, Visual |
2.9% |
Headache |
2.9% |
|
Concomitant |
Colorectal Cancer Metastatic |
23.1% |
Multiple Myeloma |
16.8% |
Multiple Sclerosis |
8.4% |
Myelodysplastic Syndrome |
5.9% |
Product Used For Unknown Indication |
5.9% |
Musculoskeletal Pain |
5.0% |
Ill-defined Disorder |
4.2% |
Drug Use For Unknown Indication |
3.8% |
Acute Myeloid Leukaemia |
3.4% |
Plasma Cell Myeloma |
3.4% |
Brain Neoplasm |
2.5% |
Surgery |
2.5% |
Depression |
2.1% |
Hypersensitivity |
2.1% |
Immunodeficiency Common Variable |
2.1% |
Insulin-like Growth Factor Decreased |
2.1% |
Colon Cancer Metastatic |
1.7% |
Gait Disturbance |
1.7% |
Non-small Cell Lung Cancer |
1.7% |
Post-traumatic Epilepsy |
1.7% |
|
Pneumonia |
16.9% |
Urinary Tract Infection |
10.1% |
White Blood Cell Count Decreased |
7.9% |
Sepsis |
5.6% |
Somnolence |
5.6% |
Vomiting |
5.6% |
Pyrexia |
4.5% |
Respiratory Failure |
4.5% |
Weight Decreased |
4.5% |
Diarrhoea |
3.4% |
Hydrocele |
3.4% |
Maternal Drugs Affecting Foetus |
3.4% |
Neutropenia |
3.4% |
Pancytopenia |
3.4% |
Renal Transplant |
3.4% |
Skin Ulcer |
3.4% |
Upper Respiratory Tract Infection |
3.4% |
Urticaria |
3.4% |
Cellulitis |
2.2% |
Condition Aggravated |
2.2% |
|